Loading...

Table of Content

    15 August 2023 Volume 41 Issue 8
      
    Commentary
    Resistance mechanism and treatment of carbapenem resistant Pseudomonas aeruginosa
    YU Hui
    Journal of Clinical Pediatrics. 2023, 41(8):  561-565.  doi:10.12372/jcp.2023.23e0487
    Abstract ( 251 )   HTML ( 29 )   PDF (1239KB) ( 177 )  
    References | Related Articles | Metrics

    Pseudomonas aeruginosa is a common opportunistic pathogen of nosocomial infection, which is widely distributed in the hospital environment and can survive for a long time. Carbapenems antibiotics play an important role in the treatment of serious infections caused by Pseudomonas aeruginosa. However, the outbreak of carbapenems resistant Pseudomonas aeruginosa is particularly prominent in recent years, which has made clinical treatment facing great challenges. This article introduces the main resistance mechanism of Pseudomonas aeruginosa to carbapenems antibiotics and summarizes the application of various clinical treatment schemes, and provides a reference clinical rational use of antibiotics and treatment of carbapenems resistant Pseudomonas aeruginosa infection

    Expert Review
    Clinical manifestations and immune mechanism of invasive pulmonary mycosis in children
    QIN Tao, XU Hongmei
    Journal of Clinical Pediatrics. 2023, 41(8):  566-570.  doi:10.12372/jcp.2023.23e0435
    Abstract ( 140 )   HTML ( 10 )   PDF (1228KB) ( 126 )  
    References | Related Articles | Metrics

    Invasive pulmonary mycosis is a fungal infection of the bronchi and lungs, causing inflammation of the airway mucosa and pulmonary inflammatory granulomas. In severe cases, necrotizing pneumonia may occur, and even hematogenous dissemination to other organs. Its occurrence and development depend on the interaction between external fungal pathogenic factors and the patient's immune function. Children with primary immune dysfunction, hematological malignancies, receiving hematopoietic stem cell transplantation or high-intensity immunosuppressive therapy, long-term invasive catheterization, or severe infections may be susceptible to fungi. This article discusses the immunological pathogenesis and clinical characteristics of invasive pulmonary mycosis in children, hoping to provide theoretical basis for the early detection of the disease.

    Strategies for the diagnosis, treatment, and management of invasive fungal infections in children with hematologic neoplasms
    SHEN Nan, DU Bailu
    Journal of Clinical Pediatrics. 2023, 41(8):  571-577.  doi:10.12372/jcp.2023.23e0416
    Abstract ( 115 )   HTML ( 10 )   PDF (1388KB) ( 210 )  
    Figures and Tables | References | Related Articles | Metrics

    Invasive fungal disease (IFD) is one of the most common types of infection in the treatment of hematologic malignancies and has a significant impact on the prognosis of pediatric patients with hematologic malignancies. In recent years, with the development of pathogen molecular detection techniques and the application of new antifungal drugs, the prognosis of IFD in pediatric patients with hematologic malignancies has been greatly improved. However, challenges such as diagnostic difficulties, complex disease conditions, and the selection of treatment drugs still exist. This article summarizes the current research progress and the latest diagnostic and therapeutic guidelines to elucidate the risk factors, clinical features, treatment strategies, and prognosis of IFD in pediatric patients with hematologic malignancies, aiming to better assist pediatricians in understanding the prevention, management, and treatment of IFD in pediatric patients with hematologic malignancies.

    Infectious Disease
    Drug analysis of polymyxin B in the treatment of severe carbapenem-resistant Gram-negative bacteria infection in children
    LIN Liangkang, LIU Zhongqiang, QIAO Lina, LI Deyuan, ZHANG Haiyang
    Journal of Clinical Pediatrics. 2023, 41(8):  578-583.  doi:10.12372/jcp.2023.22e1184
    Abstract ( 99 )   HTML ( 7 )   PDF (1238KB) ( 63 )  
    Figures and Tables | References | Related Articles | Metrics

    Objective To evaluate the efficacy and safety of polymyxin B in the treatment of carbapenem-resistant Gram-negative bacteria (CRGNB) infection in children. Methods From July 2020 to December 2021, 32 cases of carbapenem-resistant Gram-negative bacteria infection in PICU with using polymyxin B were retrospectively analysed. Results 20 patients enrolled in the retrospective cohort, 11 males and 9 females, with a median age of 3.4 (0.6-8.9) years; 12 were cured and 1 died. The underlying diseases were most frequently haemato-oncological system diseases (30.0%). Infection specimens from 20 patients were mainly detected in sputum or bronchoalveolar lavage fluid (75%), followed by blood (10%). Carbapenem-resistant Klebsiella pneumoniae was the most frequently isolated organism (35.0%, 7/20), followed by carbapenem-resistant Pseudomonas aeruginosa with 30% (6/20). Another 4 cases were mixed infection of multiple carbapenem-resistant Gram-negative bacilli.. All children were treated with a polymyxin B combination, with meropenem as the mainstay (9 cases, 45.0%), and no adverse reactions were observed in 20 cases. Of the 15 children with lower respiratory tract infections, a higher cure rate was observed in children with the addition of topical nebulisation compared to the intravenous administration of polymyxin B alone (P=0.002).Conclusion The efficacy and safety of polymyxin B in the treatment of severe carbapenem-resistant Gram-negative bacterial infection in children is worthy of affirmation. However, more and large-scale clinical studies are urgently needed for further exploration and evaluation..

    Clinical analysis of 195 children with invasive pulmonary fungal infection
    XU Beixue, LIU Quanbo
    Journal of Clinical Pediatrics. 2023, 41(8):  584-588.  doi:10.12372/jcp.2023.22e0925
    Abstract ( 157 )   HTML ( 10 )   PDF (1259KB) ( 152 )  
    Figures and Tables | References | Related Articles | Metrics

    Objective To analyze the clinical data of 195 children with invasive pulmonary fungal infection (IPFI), and to provide help for early identification and diagnosis of IPFI in children. Methods The clinical data of 195 children with IPFI were retrospectively analysed. Results Among the 195 cases, 123 were male and 72 were female, the median age was 9.5 (0.9-62.0) months. 52 were neonates (<28 d), 79 were infants (28 d-3 years), and 64 were elder children (3-18 years). The most common diseases of newborn were premature infants (75.0%), the most common diseases of infant were immunodeficiency (20.3%), and haematological diseases were more common in elder children (31.3%). The differences in the proportions of two-combination antibiotic use, haemodialysis or dialysis, indwelling gastric tube, use of glucocorticoids, chemotherapy or other immunosuppressive treatments, and parenteral nutrition were statistically significant between different age groups (P<0.05). The main pathogen was Candida albicans (69.2%), and there were significant differences in the proportion of Candida albicans, Candida tropicalis and Aspergillus among different age groups (P<0.05). Candida had a high resistance to azoles and a low resistance to amphotericin B and 5-fluorocytosine. Conclusions Invasive pulmonary fungal infections in children were predominant in infants and young children, with differences in the underlying disease and invasiveness factors in different age groups, with Candida being the predominant pathogen, and the distribution of strains of the organisms may be related to age, with a high rate of resistance to azoles inCandida.

    Role of nontypeable Haemophilus influenzae biofilms in chronic pulmonary infection in children
    CHEN Hongyu, LIU Zihao, WANG Heping, LIAO Cuijuan, LI Li, WANG Wenjian, LAI Jianwei
    Journal of Clinical Pediatrics. 2023, 41(8):  589-593.  doi:10.12372/jcp.2023.22e0427
    Abstract ( 104 )   HTML ( 5 )   PDF (1415KB) ( 49 )  
    Figures and Tables | References | Related Articles | Metrics

    Objective To investigate the role of nontypeable Haemophilus influenzae biofilm in children with chronic pulmonary infection and compare the biofilm formation of isolates from acute and chronic pulmonary infection in children. Methods Haemophilus influenzae isolated from bronchoalveolar lavage fluid of acute and chronic pulmonary infection in children was selected from the clinical microbiology lab in Shenzhen Children's Hospital, and Haemophilus influenzae isolated from the nasopharynx of healthy children was selected as the control group. And then we compared the production of biofilms at different time points and between different groups in children with acute or chronic pulmonary infection. Results All strains were nontypeable Haemophilus influenzae detected by PCR of capsular gene bexA. The difference in absorbance between acute and chronic lung infection groups at different time points (days 1, 2, 3, 4, and 7) was statistically significant, and the absorbance was the highest in the chronic infection group on day 4. On the 4th day, the difference in absorbance between the healthy control group and the acute and chronic lung infection groups was statistically significant (P<0.05). The absorbance of the chronic lung infection group was higher than that of the healthy control group and the acute lung infection group (P<0.05). Conclusion The biofilm formation of nontypeable Haemophilus influenzae takes a long time, and the formation ability in children with chronic pulmonary infection is significantly higher than that in children with acute pulmonary infection and healthy control children.

    Value of metagenomic next-generation sequencing in children with visceral leishmaniasis associated with hemolytic histiocytosis
    KANG Lei, GUO Fang, LI Lifang, BAI Xinfeng, CHENG Caiyun, XU Meixian
    Journal of Clinical Pediatrics. 2023, 41(8):  594-598.  doi:10.12372/jcp.2023.22e1301
    Abstract ( 104 )   HTML ( 3 )   PDF (1231KB) ( 255 )  
    Figures and Tables | References | Related Articles | Metrics

    Objective To investigate the application value of metagenomic next-generation sequencing (mNGS) in pediatric visceral leishmaniasis associated with hemolytic histiocytosis (VL-HLH). Methods Clinical data of children with VL-HLH diagnosed from 1 January 2016 to 30 June 2022 were retrospectively analysed. Results A total of six VL-HLH were enrolled, three cases were imported from other province, and 3 cases were local cases. Clinical manifestations of six cases include fever, splenomegaly, pancytopenia and hyperferremia, five cases combined with hypertriglyceridemia or hypofibrinogenmia., four cases with decreased NK cell activity, three cases with increased sCD25, and two cases with phagocytosis of BMA. The VL-HLH was confirmed by BMA in two cases, and the maximum interval between onset and diagnosis were 62 and 90 days, respectively; other four cases were diagnosed by mNGS, with 34-day (16.0-39.0) interval from onset. There were five cases received glucocorticoid therapy and three cases received chemotherapy due to the delayed diagnosis, and three of them were co-infected. However, two children avoided the chemotherapy for early diagnosis by mNGS, and no co-infection occurred in them. Conclusion The clinical manifestations of VL-CMV are lack of specificity, and it is difficult to diagnose early in endemic areas of non-leishmania. mNGS can provide a basis for early diagnosis of VL-CMV and provide accurate treatment in time.

    General Report
    Clinical analysis of idiopathic left ventricular tachycardia in children
    WU Xiaoling, LYU Tiewei
    Journal of Clinical Pediatrics. 2023, 41(8):  599-603.  doi:10.12372/jcp.2023.22e0465
    Abstract ( 94 )   HTML ( 5 )   PDF (1243KB) ( 71 )  
    Figures and Tables | References | Related Articles | Metrics

    Objective To analyse and summarize the clinical characteristics and treatment of idiopathic left ventricular tachycardia (ILVT) in children. Method The clinical data of 31 children with ILVT hospitalized in our hospital from January 2010 to April 2021 were retrospectively analysed. Results The median first onset age of 31 children with idiopathic left ventricular tachycardia was 7.8(3.3-10.8) years. There were 21 males and 10 females, with 18 cases (58.1%) whose first onset age was 6 to 18 years. The first onset age of 14 children who received radiofrequency catheter ablation (operation group) was 9.4(6.7-11.7) years, which was greater than that of the children who did not undergo radiofrequency ablation [non-surgical group, 17 cases, 5.4 (0.4-9.6) years old], with a statistically significant difference (P<0.05). Twenty-seven episodes of ventricular tachycardia had no clear triggering cause. 10 cases had panic, chest tightness, and precordial discomfort as the main clinical manifestations. The difference in the distribution of clinical symptom severity between the non-surgical group and the surgical group was statistically significant (P<0.05), with the non-surgical group having milder clinical manifestations.Verapamil and propafenone are more effective among vein-injected antiarrhythmic drugs and the effective rates were 100% and 64.7% respectively. The immediate success rate of radiofrequency catheter ablation was 100%, and two cases got recovered after reoperation during long-term follow-up. Conclusion ILVT occurs mostly in school age, with no clear inducement, and its manifestations are not serious. Most patients have good response to drugs and favourable prognosis. Radiofrequency catheter ablation is feasible for patients with recurrent attacks and poor drug efficacy.

    Efficacy and safety of fosaprepitant in the prevention of highly emetogenic chemotherapy-related nausea and vomiting in pediatric patients with cancer
    YU Liting, SHEN Xingwei, WANG Zhuo, ZHANG Shunguo, GAO Yijin
    Journal of Clinical Pediatrics. 2023, 41(8):  604-609.  doi:10.12372/jcp.2023.22e0483
    Abstract ( 98 )   HTML ( 5 )   PDF (1279KB) ( 104 )  
    Figures and Tables | References | Related Articles | Metrics

    Objective To investigate the clinical efficacy and safety of fosaprepitant in preventing nausea and vomiting caused by highly emetogenic chemotherapy (HEC) in children with cancer. Methods Pediatric cancer patients who received fosaprepitant to manage HEC-induced nausea and vomiting in the Department of Hematology and Oncology of Shanghai Children's Medical Center between July 2021 and November 2021 were enrolled into this study. The patients treated with fosaprepitant+ondansetron+dexamethasone were included in the fosaprepitant group, and the patients treated with ondansetron+dexamethasone were included in the control group. The clinical efficacy was evaluated by the difference of complete response (CCR, no vomiting/rescue medication) of acute, delayed and overall phase vomiting between the two groups. The safety assessment was carried out using the Common Terminology Criteria for Adverse Events v4.0 (National Cancer Institute). Results 107 patients were enrolled in this study (55 in the fosaprepitant group and 52 in the control group). There were 51 males and 56 females, with a median age of 3.5 (1.42-7.33) years. CCR rates were higher in the fosaprepitant group comparing that in the control group during the acute, delayed vomiting and overall phases, a lower proportion of children with mild and moderate vomiting, and no children with severe vomiting. Adverse reactions occurred in 25 cases (45.5%) in the fosaprepitant group, with a lower incidence rate than that in the control group (34 cases, 65.4%), and the difference was statistically significant (P<0.05). No severe adverse event was observed in this study. The difference in the incidence of headache, anorexia, malaise and other adverse reactions between the two groups of children was not statistically significant (P>0.05). Conclusion Fosaprepitant combined with ondansetron and dexamethasone is effective and safe in preventing related nausea and vomiting in children with cancer.

    Clinical analysis of 15 children with primary nephrotic syndrome complicated with adrenal crisis
    SUN Zhicai, LIU Yuling, LI Xiaolin, PAN Xiaofen
    Journal of Clinical Pediatrics. 2023, 41(8):  610-612.  doi:10.12372/jcp.2023.22e0900
    Abstract ( 135 )   HTML ( 9 )   PDF (1218KB) ( 86 )  
    References | Related Articles | Metrics

    Objective To investigate the clinical characteristics and prognosis of primary nephrotic syndrome (PNS) complicated with adrenal crisis (AC) in children. Methods Clinical data of 15 patients with primary nephrotic syndrome complicated with adrenal crisis in the department of Pediatrics, Boai Hospital, Zhongshan City from January 2010 to March 2022 were retrospectively analyzed. Results The average age of the patients was 6.25±1.81 years old (4.75-12 years old), including 9 males and 6 females. The course of disease was 2.74±1.33 years (1-6 years). Inducement: Glucocorticoid dose reduction or withdrawal in 8 cases, respiratory tract infections in 5 cases, and no obvious triggers in 2 cases. Clinical manifestations: Gastrointestinal symptoms such as abdominal pain, nausea, and vomiting were found in 11 cases, circulatory failure manifestations such as low blood pressure and oliguria in 7 cases, hyponatremia in 8 cases, hyperkalemia in 4 cases, and hypoglycaemia in 2 cases, All the children were accompanied by neurological symptoms of varying degrees (such as dizziness, debilitation, malaise or irritability, etc.). Serum cortisol: Random serum cortisol level of 9 children with digestive tract or early shock symptoms was 37.6±15.7 nmol/ L (15.3-52.7 nmol/ L), fasting serum cortisol level was 56.3±18.9 nmol/ L (21.6-73.4 nmol/L) at 8 am in 6 patients. Treatment and prognosis: Symptoms were effectively controlled in all children after 2-3 days of intravenous hydrocortisone treatment. After follow-up to June 2022, 11 cases of PNS were cured, 4 cases of PNS were still under treatment, and there was no recurrence of AC. Conclusion Primary nephrotic syndrome in children with adrenal crisis is mainly caused by hormone abatement or infection, and the symptoms of digestive and circulatory system are the main manifestations. Early identification and timely treatment have a good prognosis.

    Clinical characteristics and genetic analysis in Chinese patients with Menke-Hennekam syndrome
    TANG Yanan, YE Xiantao, GU Xuefan, YU Yongguo, XIAO Bing, SUN Yu
    Journal of Clinical Pediatrics. 2023, 41(8):  613-617.  doi:10.12372/jcp.2023.22e1597
    Abstract ( 250 )   HTML ( 8 )   PDF (1231KB) ( 141 )  
    Figures and Tables | References | Related Articles | Metrics

    ObjectiveTo explore the clinical phenotype and identify genetic variations in Chinese patients with Menke-Hennekam syndrome (MKHK). Methods The clinical and genetic data of seven children with MKHK were retrospectively analyzed. Results All of the seven children are presented with psychomotor developmental delay, variable degree of intellectual disability, short stature, and facial dysmorphism (including short and upslanted palpebral fissures, telecanthi, depressed nasal bridge, short nose, long philtrum, protruding or low-set ears and micrognathia), accompanied by other manifestations (2/7 feeding problems, 4/7 visual impairment, 3/7 hearing impairment, 3/7 cerebral anomaly, 2/7 distal limb malformation). The genetic findings of patientsinvolve six different variants: five missense and one in-frame deletion), all of which arose de novo. c.5218C>T and c.5225T>A (NM_004380.3) variants have not been reported previously in literature. Conclusion MKHK is a rare autosomal dominant genetic disease, most of which are caused by heterozygous missense variation in the end of exon 30 and the beginning of exon 31 of CREBBP. This study revealed six de novo variants of CREBBP, further expanding the genetic spectrum of MKHK.

    Clinical and genetic analysis of Wiedemann-Steiner syndrome caused by KMT2A gene mutation in three cases
    LIU Suying, LI Fang, MA Hongwei
    Journal of Clinical Pediatrics. 2023, 41(8):  618-623.  doi:10.12372/jcp.2023.22e0472
    Abstract ( 158 )   HTML ( 10 )   PDF (1272KB) ( 107 )  
    Figures and Tables | References | Related Articles | Metrics

    Objective To report the clinical and genetic characteristics of three cases of Wiedemann-Steiner syndrome (WDSTS) caused by KMT2A gene mutation, and improve the understanding of the disease and the efficiency of diagnosis and treatment. Methods The clinical data of three cases of WDSTS caused by KMT2A gene mutation in three families diagnosed in Shengjing Hospital of China Medical University from December 2019 to September 2021 were reviewed, and the clinical and genetic characteristics of WDSTS patients reported in the literature were reviewed and summarized. Results All three cases were diagnosed in infancy, with the youngest age of diagnosis of two months old, and the reasons for consultation were growth retardation and anorexia, respectively. Similar to those in previous literature, the clinical manifestations were special facial features, malnutrition (3/3), feeding difficulties, sleep disorders, hirsutism (2/3), and developmental delay (1/3). The clinical manifestations that had not been reported before were umbilical hernia and inguinal hernia. All three cases were de novo frameshift variants, which occurred in exon 3 and 27 in hot spot variants region and exon 11 in non-hot spot variants region, respectively. Conclusions Wiedemann-Steiner syndrome should be considered in children with malnutrition, feeding difficulty and developmental delay, combined with special facial features and specific hirsute. High-throughput exome sequencing should be used to facilitate early diagnosis. De novo frameshift variants of KMT2A gene are common, with hot spots in exon 27 and 3. The three unreported frameshift variants in this study enrich the mutation spectrum of this gene. In addition, patients with variants in the CXXC region of the KMT2A gene may have a more severe clinical phenotype.

    Report a case of α-ketoadipic aciduria caused by compound heterozygous variant of DHTKD1 gene
    WANG Hongxia, PAN Xiang, LU Jun
    Journal of Clinical Pediatrics. 2023, 41(8):  624-628.  doi:10.12372/jcp.2023.22e0486
    Abstract ( 160 )   HTML ( 24 )   PDF (1708KB) ( 107 )  
    Figures and Tables | References | Related Articles | Metrics

    Alpha-ketoadipic aciduria is a genetic metabolic disease caused by the disorder of lysine, hydroxylysine and tryptophan degradation metabolism. The clinical manifestations of the disease vary in severity and affect a wide range of systems. The main clinical manifestations include growth retardation, hypotonia, epilepsy, ataxia, microcephaly and abnormal behavior. The patient was 2 years and 8 months old and presented with convulsions and behavioral abnor malities. Urine organic acid analysis showed that α-ketoadipic acid was significantly increased. Genetic testing revealed that DHTKD1 gene had pathogenic compound heterozygous variation. Combined with the clinical and genetic characteristics of the child, the diagnosis of α-ketoadipic aciduria was confirmed. The patient's condition improved after symptomatic treatment with a low lysine and protein diet and rehabilitation. This is the first report of α-ketoadipic aciduria in Chinese medical database, which expands the genetic spectrum of α-ketoadipic aciduria and provides reference for clinical diagnosis and treatment of the disease.

    Literature Review
    Research advances of the bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplant in children
    XI Bixin, HU Qun, LIU Aiguo
    Journal of Clinical Pediatrics. 2023, 41(8):  629-633.  doi:10.12372/jcp.2023.22e1137
    Abstract ( 119 )   HTML ( 13 )   PDF (1216KB) ( 227 )  
    Figures and Tables | References | Related Articles | Metrics

    Bronchiolitis obliterans syndrome (BOS) is one of the rare and fatal non-infectious pulmonary complications after allogeneic haematopoietic stem cell transplantation (HSCT) in children. Mutiple risk factors such as primary graft dysfunction, graft-versus-host disease (GVHD), lymphocytic bronchiolitis, gastro-oesophageal reflux, and air pollution, particularly in children, have been reported to be the most common contributions to the bronchiolitis obliterans syndromepost-HSCT. An early diagnosis and treatment of BOS following HSCT is challenging due to the lack of obvious early symptoms, high risk of open lung biopsy, irreversible pathophysiological changes, and the failure of steroid treatment in some children. In this review, we summarize research advances in the epidemiology, pathogenesis, diagnosis, and treatment of this lethal noninfectious pulmonary complication, and provide suggestions for further improvement of diagnostic and therapeutic norms applicable to post-HSCT BOS in children.

    Continuing Medical Education
    Research progress on the role of intestinal flora in sepsis
    WANG Yanfei, TAN Linhua
    Journal of Clinical Pediatrics. 2023, 41(8):  634-640.  doi:10.12372/jcp.2023.22e0820
    Abstract ( 120 )   HTML ( 13 )   PDF (1259KB) ( 332 )  
    References | Related Articles | Metrics

    Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection which affects children's health. The intestinal flora play an important regulatory role in host metabolism and immunity and are associated with a variety of diseases. Studies have shown that sepsis and clinical treatments can lead to intestinal flora imbalance in children, which further affects the prognosis of the disease; while healthy intestinal flora can reduce the susceptibility of children to sepsis and improve the survival of sepsis, and ameliorate the damage to the function of organs. This article reviews the related research on intestinal flora and sepsis, in order to contribute to the prevention and treatment of sepsis in children.